ArticleThoracic cancer2021

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer.

Taisuke Isono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.